18 related articles for article (PubMed ID: 2683263)
1. Immunomodulation therapy for severe aplastic anemia--ALG versus ALG plus cyclosporin A.
Park CW; Han CH; Kim CC; Kim DJ; Kim HK
Korean J Intern Med; 1989 Jan; 4(1):28-33. PubMed ID: 2487402
[TBL] [Abstract][Full Text] [Related]
2. Prevention of DGF: another brick in the wall.
Legendre C
Am J Transplant; 2024 Jun; ():. PubMed ID: 38876366
[No Abstract] [Full Text] [Related]
3. Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients.
Hill P; Cross NB; Barnett AN; Palmer SC; Webster AC
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD004759. PubMed ID: 28073178
[TBL] [Abstract][Full Text] [Related]
4. Prevention of transplant rejection: current treatment guidelines and future developments.
Perico N; Remuzzi G
Drugs; 1997 Oct; 54(4):533-70. PubMed ID: 9339960
[TBL] [Abstract][Full Text] [Related]
5. Individualization of immediate posttransplant immunosuppression. The value of antilymphocyte globulin in patients with delayed graft function.
Matas AJ; Tellis VA; Quinn TA; Glicklich D; Soberman R; Veith FJ
Transplantation; 1988 Feb; 45(2):406-9. PubMed ID: 3278434
[TBL] [Abstract][Full Text] [Related]
6. A prospective randomized comparison of quadruple versus triple therapy for first cadaver transplants with immediate function.
Slakey DP; Johnson CP; Callaluce RD; Browne BJ; Zhu YR; Roza AM; Adams MB
Transplantation; 1993 Oct; 56(4):827-31. PubMed ID: 8212201
[TBL] [Abstract][Full Text] [Related]
7. The effects of delayed function on recipients of cadaver renal allografts. A study of 158 patients randomized to cyclosporine or ALG-azathioprine.
Canafax DM; Torres A; Fryd DS; Heil JE; Strand MH; Ascher NL; Payne WD; Sutherland DE; Simmons RL; Najarian JS
Transplantation; 1986 Feb; 41(2):177-81. PubMed ID: 3511581
[TBL] [Abstract][Full Text] [Related]
8. Results of the Minnesota randomized prospective trial of cyclosporine versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients.
Sutherland DE; Fryd DS; Strand MH; Canafax DM; Ascher NL; Payne WD; Simmons RL; Najarian JS
Am J Kidney Dis; 1985 Jun; 5(6):318-27. PubMed ID: 3893106
[TBL] [Abstract][Full Text] [Related]
9. A randomized trial comparing cyclosporine with antilymphoblast-globulin-azathioprine for renal allograft recipients. Results at 2 1/2-6 years.
Johnson CP; Simmons RL; Sutherland DE; Canafax DM; Ascher NL; Payne WD; Flick B; Najarian JS; Fryd DS
Transplantation; 1988 Feb; 45(2):380-5. PubMed ID: 3278431
[TBL] [Abstract][Full Text] [Related]
10. A comparison of the effects of cyclosporine versus antilymphocyte globulin on delayed graft function in cadaver renal transplant recipients.
Michael HJ; Francos GC; Burke JF; Besarab A; Moritz M; Gillum D; Jarrell B
Transplantation; 1989 Nov; 48(5):805-8. PubMed ID: 2683263
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
